Base-Edited CAR-T (Universal)

Type: cell_therapy

Status: Investigational (landmark UK case)

Developer: Great Ormond Street / Beam Therapeutics

Breakthrough Summary

No summary available.

Mechanism of Action

Donor-derived T-cells with base-edited genes to avoid rejection; off-the-shelf

Year: 2024-2026